Evidence map›Paper›PMID 9580707›Full record

ArticleNucleic acids research1998

Oligoribonucleotide circularization by 'template-mediated' ligation with T4 RNA ligase: synthesis of circular hammerhead ribozymes.

L Wang, D E Ruffner

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. The therapeutic potential of circular RNAs.Nature reviews. Genetics · 2025
    Review
  4. Review
  5. Review
  6. Circular RNA vaccine in disease prevention and treatment.Signal transduction and targeted therapy · 2023
    Review
  7. Pros and Cons of In Vitro Methods for Circular RNA Preparation.International journal of molecular sciences · 2022
    Review
  8. Phospho-RNA sequencing with circAID-p-seq.Nucleic acids research · 2022
    Article
  9. The design and synthesis of circular RNAs.Methods (San Diego, Calif.) · 2021
    Review
  10. Circular RNA: BiosynthesisFrontiers in bioengineering and biotechnology · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

L WangDepartment of Bioengineering, University of Utah, 421 Wakara Way, Suite 318, Salt Lake City, UT 84108, USA.
D E Ruffner
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
RIBOZYMES--TARGET SITE SELECTION AND DRUG DELIVERYR29AI034278 · NIAID · UNIVERSITY OF UTAH · PI RUFFNER, DUANE F · 1994 to 1998
–
NCI NIH HHS CA42014NIAID NIH HHS 5R29AI34278
6 · The paper itself

Abstract

Circular hammerhead ribozymes were synthesized from linear oligoribonucleotides using T4 RNA ligase. Some of the precursors could not be efficiently circularized under standard conditions. For these molecules, the use of a DNA template allowed their efficient circularization. The template was designed to prevent the precursor from folding into an unsuitable structure. The template allowed circular ribozymes as small as 15 nucleotides in length to be efficiently synthesized at concentrations as high as 50 microM in the ligation reaction. The circular products retained their biological activity.

Indexed as

RNA Ligase (ATP)Bacteriophage T4DNADNA, CircularNucleic Acid ConformationOligoribonucleotidesRNA, CatalyticTemplates, GeneticDNADNA, CircularOligoribonucleotidesRNA, CatalyticRNA Ligase (ATP)

Identifiers

PMID9580707
PMCPMC147549
OpenAlexW1983775172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.